NCT03289169View on ClinicalTrials.gov

Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

December 30, 2016

Primary Completion Date

May 29, 2019

Study Completion Date

May 29, 2019

Conditions
Glabellar Frown Lines
Interventions
DRUG

MEDITOXIN®

20U of Meditoxin® is injected to two places on the corrugators muscle for each eye and one place on the procerus muscle, total of 5 sites.

Trial Locations (1)

130-709

St. Paul Hospital, Seoul

All Listed Sponsors
lead

Medy-Tox

INDUSTRY

NCT03289169 - Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines | Biotech Hunter | Biotech Hunter